
RetiSpec
@retispec
RetiSpec is developing an AI-driven solution for early detection of Alzheimer’s disease through a simple eye exam
ID: 737362821038624769
http://RetiSpec.ai 30-05-2016 19:19:30
539 Tweet
466 Followers
759 Following



DxA-funded RetiSpec recently announced a $10M Series A #funding round by investors like Eli Lilly and Company and Topcon Healthcare to advance the commercialization of its #AI-powered #EyeTest for the detection of #Alzheimers. Learn more here: bit.ly/4ggvRHU Medical Technology & Medical Device Network







ICYMI: CABHI,propulsé par Baycrest s'est associé à ECHAlliance: The Global Health Connector HLTH à Las Vegas. Nous avons collaboré avec District 3 Innovation & le Health Technology Catalyst & MaRS pour présenter plus de 30 entreprises canadiennes de technologie de la santé sur la scène internationale.🌎



🏆 Congratulations to Andre Charoo - Charter Member & former Board Co-Chair - on winning the Shawn Price Leadership Award! While Co-Chair (w/ Janet Bannister) he helped steer the organization during a leadership transition & shared his expansion expertise to shape the Fellows program.




AI-powered tools like tech from MIMOSA Diagnostics, Linda Lifetech, RetiSpec & Tenomix are helping accelerating healthcare diagnostics, but adoption is lagging in Canada. Learn more on what needs to be done to allow AI be more quickly embraced in healthcare. canhealth.com/2024/11/01/why…



This #AlzheimersAwarenessMonth, discover how neurotechnology is transforming dementia care. 🧠Join experts Catherine Bornbaum (RetiSpec), Lia Tsotsos (Sheridan Centre for Elder Research), and Shawn Paron (Alzheimer Society of Ontario) as they explore groundbreaking solutions to empower seniors to defy #dementia.


